
Read & Publish: what authors say
Corresponding authors at institutions that are participating in our Read & Publish Open Access initiative can publish an uncapped number of research articles immediately Open Access without paying an article processing charge (APC) in:
- our hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology)
- our fully Open Access journals (Disease Models & Mechanisms and Biology Open)
As you will see from the many comments below, we have had wonderful feedback from authors who have benefitted from Read & Publish agreements arranged by their institutional libraries. You can choose to select quotes by journal and/or region and, once you have made your selection, click the blue button to activate the filter.
A range of video interviews is available here.
Quotes
Steve Jean, Universite de Sherbrooke, Canada
“The Université de Sherbrooke’s Read & Publish agreement with The Company of Biologists provided us with a wonderful opportunity to publish our recent work in an Open Access format in a prestigious journal at no cost. Given the high-quality review process offered by the journals of The Company of Biologists and the unique benefits of the Read & Publish agreement, we will continue submitting our best work to their journals.”
Clare Muir, The University of Edinburgh, UK
“We are delighted that our article has been published in Disease Models & Mechanisms fee-free and Open Access under the Read & Publish agreement with The University of Edinburgh. Our science is now available for everyone to read, regardless of financial status. We are thrilled that our organisation and The Company of Biologists support the work of scientists, not for profit, but for curiosity-driven science. We are also delighted that a common hawthorn tree has been planted in The Forest of Biologists in recognition of our article.”

Liang Zheng, University of Kansas Medical Center, USA
“Open Access greatly helps our paper reach a broader scientific and general audience. We are glad and grateful that the Read & Publish agreement between The Company of Biologists and our institution covers our Open Access publication cost. This publisher remains a preferred platform for us to publish our work.”
James J. P. Alix, University of Sheffield, UK
“Publishing Open Access with DMM was easy to do and really important for the way that we as scientists and our funder, the MNDA, want to communicate our work.”
Luis R. Martinez, University of Florida, USA
“I already knew about the outstanding reputation of Disease Models & Mechanisms (DMM) and The Company of Biologists. However, when I learned that the University of Florida has a Read & Publish agreement that included free Open Access publication in DMM, I was delighted. The submission, review, and publication stages of our article exceeded my expectations. Perhaps, the biggest surprise was that they planted a tree in The Forest of Biologists in recognition of our article. This initiative is lovely. I encourage any university to support their investigators by providing them the opportunity to publish free, Open Access, and high quality articles through similar agreements.”

Rita Aires, Technische Universität Dresden, Germany
“Open Access is crucial to make research available to everyone, anytime. Knowing that the Technische Universität Dresden, through its state library (SLUB), was part of the Read & Publish Open Access initiative made our choice of journal a lot easier, especially when this agreement comprises high-quality journals such as Disease Models & Mechanisms. Not having to use valuable funding for an APC was a welcome change and will encourage me to publish again in journals from The Company of Biologists. I hope this paves the way for other publishers to join similar agreements so that science can become more inclusive and equitable!”

Kavita Panir, The University of Adelaide, Australia
“Thanks to the Read & Publish Open Access agreement between The University of Adelaide and The Company of Biologists, publishing my PhD research in Disease Models & Mechanisms was seamless. The process was smooth, with clear communication at every stage, and the agreement allowed me to publish without fees, making my work freely accessible to a global audience. I’m grateful for this initiative, which promotes wider scientific communication and knowledge sharing.”
